Charles River Laboratories International, Inc. Share Price
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
229 USD | +0.54% | +0.99% | -3.12% |
Sales 2024 * | 4.22B 338B | Sales 2025 * | 4.54B 364B | Capitalization | 11.76B 941B |
---|---|---|---|---|---|
Net income 2024 * | 420M 33.62B | Net income 2025 * | 525M 42.03B | EV / Sales 2024 * | 3.25 x |
Net Debt 2024 * | 1.98B 159B | Net Debt 2025 * | 1.51B 121B | EV / Sales 2025 * | 2.92 x |
P/E ratio 2024 * |
28.3
x | P/E ratio 2025 * |
23
x | Employees | 21,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.19% |
Latest transcript on Charles River Laboratories International, Inc.
1 day | +0.54% | ||
1 week | +0.99% | ||
Current month | -15.47% | ||
1 month | -14.98% | ||
3 months | +3.97% | ||
6 months | +32.70% | ||
Current year | -3.12% |
Managers | Title | Age | Since |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 31/12/75 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 24/04/22 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 31/03/89 |
Members of the board | Title | Age | Since |
---|---|---|---|
C. Reese
BRD | Director/Board Member | 78 | 02/12/07 |
George Massaro
BRD | Director/Board Member | 76 | 31/12/02 |
Virginia Wilson
BRD | Director/Board Member | 68 | 30/09/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.05% | 1 M€ | -5.79% | - | |
2.07% | 5 M€ | -1.80% | - | |
1.08% | 0 M€ | 0.00% | - | |
0.98% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 229 | +0.54% | 322,127 |
25/04/24 | 227.8 | -4.85% | 762,872 |
24/04/24 | 239.4 | -0.29% | 705,117 |
23/04/24 | 240.1 | +3.26% | 611,881 |
22/04/24 | 232.6 | +2.55% | 544,691 |
Delayed Quote Nyse, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.12% | 11.76B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
+6.35% | 11B | |
-16.98% | 10.07B |
- Stock Market
- Equities
- CRL Stock